AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -60.0% | 28,500 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $5,000 | -61.5% | 28,500 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $13,000 | -56.7% | 28,500 | -46.7% | 0.00% | -50.0% |
Q4 2021 | $30,000 | -66.3% | 53,500 | 0.0% | 0.01% | -61.9% |
Q3 2021 | $89,000 | -21.9% | 53,500 | -21.9% | 0.02% | -19.2% |
Q2 2021 | $114,000 | -1.7% | 68,500 | 0.0% | 0.03% | -7.1% |
Q1 2021 | $116,000 | +6.4% | 68,500 | 0.0% | 0.03% | -3.4% |
Q4 2020 | $109,000 | +354.2% | 68,500 | +168.6% | 0.03% | +314.3% |
Q3 2020 | $24,000 | +50.0% | 25,500 | 0.0% | 0.01% | +40.0% |
Q2 2020 | $16,000 | +6.7% | 25,500 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $15,000 | +15.4% | 25,500 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $13,000 | +30.0% | 25,500 | 0.0% | 0.00% | +33.3% |
Q2 2019 | $10,000 | -47.4% | 25,500 | -23.9% | 0.00% | -40.0% |
Q1 2019 | $19,000 | +26.7% | 33,500 | -10.7% | 0.01% | -16.7% |
Q4 2018 | $15,000 | -86.4% | 37,500 | -25.0% | 0.01% | -85.7% |
Q2 2018 | $110,000 | -35.3% | 50,000 | 0.0% | 0.04% | -37.3% |
Q1 2018 | $170,000 | – | 50,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |